Halozyme Therapeutics, Inc. (HALO)

65.48 -1.10 (-1.66%) USD  |  NASDAQ  |  Apr 24, 11:46
More

Halozyme Therapeutics Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Baxter International, Inc. Upgrade
Glaukos Corp. Upgrade